AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 57 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,342,000 | +8.7% | 240,000 | -8.9% | 0.42% | +59.2% |
| Q4 2021 | $1,235,000 | -56.1% | 263,400 | -42.2% | 0.26% | -50.2% |
| Q3 2021 | $2,816,000 | -34.0% | 455,600 | -29.6% | 0.53% | -25.7% |
| Q2 2021 | $4,264,000 | -30.2% | 647,000 | -22.5% | 0.71% | -21.2% |
| Q1 2021 | $6,112,000 | +1702.9% | 835,000 | +1320.1% | 0.90% | +1940.9% |
| Q4 2020 | $339,000 | – | 58,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,986,176 | $12,275,000 | 2.58% |
| Worth Venture Partners, LLC | 454,364 | $2,808,000 | 1.26% |
| Opaleye Management Inc. | 455,600 | $2,816,000 | 0.53% |
| J. Goldman & Co LP | 1,663,229 | $10,279,000 | 0.52% |
| X-Square Capital, LLC | 92,283 | $570,000 | 0.30% |
| NEA Management Company, LLC | 3,952,958 | $24,429,000 | 0.29% |
| Birchview Capital, LP | 40,000 | $247,000 | 0.17% |
| PERSONAL CFO SOLUTIONS, LLC | 23,000 | $142,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 147,574 | $912,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 35,232 | $218,000 | 0.02% |